🇪🇺 OBINUTUZUMAB in European Union

OBINUTUZUMAB (OBINUTUZUMAB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002799
  • Local brand name: Gazyvaro
  • Status: approved

OBINUTUZUMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is OBINUTUZUMAB approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for OBINUTUZUMAB in European Union?

Marketing authorisation holder not available in our data.